Search results
Results from the WOW.Com Content Network
Carcinoembryonic antigen (CEA) describes a set of highly-related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Consequently, CEA is usually present at very low levels in the blood of healthy adults (about 2–4 ng/mL). [2]
This occurs most commonly after the treatment of lymphomas and leukemias and in particular when treating non-Hodgkin lymphoma, acute myeloid leukemia, and acute lymphoblastic leukemia. [ 2 ] [ 3 ] This is a potentially fatal complication and people at an increased risk for TLS should be closely monitored while receiving chemotherapy and should ...
Markers can help with assessing prognosis, surveilling patients after surgical removal of tumors, and even predicting drug-response and monitor therapy. [1] Tumor markers can be molecules that are produced in higher amounts by cancer cells than normal cells, but can also be produced by other cells from a reaction with the cancer. [2]
After cancer treatment ends patients will also usually have check-ups and scans arranged. Macmillan reminds us patients may need to recover from the emotional impacts, perhaps feeling anxious or ...
You may have heard of ‘chemo brain;’ some chemo patients describe experiencing memory problems, difficulty concentrating, and a feeling of mental fogginess during or after chemotherapy.”
The private and often reserved 42-year-old’s words offered a rare glimpse into her experience with cancer, a journey that prompted her to step back from public duties to undergo treatment.
Serum levels of carcinoembryonic antigen (CEA) and CA19-9 are often elevated, but are not sensitive or specific enough to be used as a general screening tool. They may be useful in conjunction with imaging methods in supporting a suspected diagnosis of cholangiocarcinoma.
A study was conducted where CA 242 serum levels were acquired from 34, 680 patients with 27 clinically defined diseases. The data acquired shows that patients with pancreatic cancer, cervical cancer and lymphoma had the highest levels of the CA 242 serum, which was followed by esophageal, colon and ovarian cancer. CA 242 can be shown to detect ...